1Timothy C. Evans, and Peter Capell, MD CLINICAL DIABETESVOL. 18 NO. 1 Winter,2000.
2HirofumiTomita, Ryan BSanford, OliverSmithies et al. The kallikrein-kinin system in diabetic nephropathy Kidney International, 2012,81 : 733-744.
3Ito S, Rump LC, ROADMAP Trim Investigators, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. The New England journal of medicine,2011,364(10) :907-917.
4Francesco Locatelli, Bernard Canaud, Kai-Uwe Eckardt, et al. The importance of diabetic nephropathy in current nephrological practice Nephrol. Dial. Transplant, 2003, 18: 1716-1725.
5Maristela LikaOnozato, AkihiroTojo, AtsuoGoto, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB, Kidney International ,2002,61 : 186-194.
7Ma YC, Li Z, Chen JH, et al. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease [ J ]. J Am Soc Nephro1,2006 , 17:2937-44.
